RNF43 and colorectal carcinoma: Unexpectedly, some of the frequent RNF43 mutations found in CRC patients, including the most common RNF43-G659Vfs, actually retain the ability to eliminate FZDs from the cell membrane and attenuate Wnt/β-catenin signaling (at least in a FZD overexpression cell culture system) (48, 49).